Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 1
2011 2
2012 7
2013 5
2014 2
2015 3
2017 3
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean seiko a[au] (4 results)?
Melanoma-induced immunosuppression and its neutralization.
Umansky V, Sevko A. Umansky V, et al. Among authors: sevko a. Semin Cancer Biol. 2012 Aug;22(4):319-26. doi: 10.1016/j.semcancer.2012.02.003. Epub 2012 Feb 13. Semin Cancer Biol. 2012. PMID: 22349515 Review.
Myeloid-derived suppressor cells in malignant melanoma.
Umansky V, Sevko A, Gebhardt C, Utikal J. Umansky V, et al. Among authors: sevko a. J Dtsch Dermatol Ges. 2014 Nov;12(11):1021-7. doi: 10.1111/ddg.12411. Epub 2014 Sep 28. J Dtsch Dermatol Ges. 2014. PMID: 25263083 Review. English, German.
Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer.
Ge Y, Böhm HH, Rathinasamy A, Xydia M, Hu X, Pincha M, Umansky L, Breyer C, Hillier M, Bonertz A, Sevko A, Domschke C, Schuetz F, Frebel H, Dettling S, Herold-Mende C, Reissfelder C, Weitz J, Umansky V, Beckhove P. Ge Y, et al. Among authors: sevko a. Cancer Immunol Res. 2019 Dec;7(12):1998-2012. doi: 10.1158/2326-6066.CIR-18-0763. Epub 2019 Oct 31. Cancer Immunol Res. 2019. PMID: 31672785 Free article.
Tumor microenvironment and myeloid-derived suppressor cells.
Umansky V, Sevko A. Umansky V, et al. Among authors: sevko a. Cancer Microenviron. 2013 Aug;6(2):169-77. doi: 10.1007/s12307-012-0126-7. Epub 2012 Dec 16. Cancer Microenviron. 2013. PMID: 23242672 Free PMC article.
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment.
Ridder K, Sevko A, Heide J, Dams M, Rupp AK, Macas J, Starmann J, Tjwa M, Plate KH, Sültmann H, Altevogt P, Umansky V, Momma S. Ridder K, et al. Among authors: sevko a. Oncoimmunology. 2015 Mar 19;4(6):e1008371. doi: 10.1080/2162402X.2015.1008371. eCollection 2015 Jun. Oncoimmunology. 2015. PMID: 26155418 Free PMC article.
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.
Gatti L, Sevko A, De Cesare M, Arrighetti N, Manenti G, Ciusani E, Verderio P, Ciniselli CM, Cominetti D, Carenini N, Corna E, Zaffaroni N, Rodolfo M, Rivoltini L, Umansky V, Perego P. Gatti L, et al. Among authors: sevko a. Oncotarget. 2014 Jun 30;5(12):4516-28. doi: 10.18632/oncotarget.2065. Oncotarget. 2014. PMID: 24980831 Free PMC article.
[Viral cancerogenesis: current point of view].
Alibek K, Sevko AL, Olishevskiĭ SV, Klimenko T. Alibek K, et al. Among authors: sevko al. Lik Sprava. 2007 Jul-Sep;(5-6):3-25. Lik Sprava. 2007. PMID: 18416158 Review. Russian.
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page